Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, B-Cell 3Leukemia, Lymphocytic, Chronic, B-Cell 3Neoplasms 1Lymphoproliferative Disorders 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma 1Lymphatic Diseases 1Leukemia, B-Cell 1Leukemia 1

Interventions

fludarabine 6Tacrolimus 6Busulfan 6blinatumomab 5Rituximab 5Cyclophosphamide 5fludarabine phosphate 4Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Epoetin Alfa 4venetoclax 3Whole-Body Irradiation 3Methotrexate 3Darbepoetin alfa 3Alemtuzumab 3ponatinib 2ibrutinib 2entrectinib 2alectinib 2Thiotepa 2Therapeutics 2Patient Reported Outcome Measures 2Mesna 2Melphalan 2Everolimus 2Early Intervention, Educational 2Bone Marrow Transplantation 2Antilymphocyte Serum 2vandetanib 1trametinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoproliferative Disorders × DTRMWXHS-12 × Other hematologic neoplasm × Clear all
NCT04305444 2025-01-08

Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas

Zhejiang DTRM Biopharma

Phase 2 Terminated
55 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphatic Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡